> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Working with Stakeholders on Opioid Use: Throckmorton
- URL: https://www.fdaweb.com/fda-working-with-stakeholders-on-opioid-use-throckmorton/
- Published: 2016-12-06T12:00:00.000Z
- Updated: 2026-09-14T21:52:46.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5137501

CDER deputy director for regulatory programs **Douglas Throckmorton** says that FDA’s work to improve the safe use of opioids is “taking place within a larger policy framework aimed at addressing opioid abuse while supporting appropriate access to pain treatment. In an [update](http://www.fda.gov/downloads/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDER/UCM531718.pdf?ref=fdaweb.com) on the agency’s opioid action plan, he says that since the plan was announced, the agency has made “significant progress” on the items identified in the plan, applying all of its available tools to achieving its goals.

He says that ongoing and planned activities reflect the agency’s commitment to work with other stakeholders to integrate the use of available tools to achieve goals related to the safe and appropriate use of prescription opioids.

“Engagement with outside experts, including help from Science Board, continues to be an important focus of FDA activities,” he says.